Page last updated: 2024-09-03

alliin and ER-Negative PR-Negative HER2-Negative Breast Cancer

alliin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aguilar-Lemarroy, A; Bravo-Cuellar, A; Haramati, J; Hernández-Flores, G; Jave-Suárez, LF; Ortiz-Lazareno, PC; Rosas-González, VC; Solorzano-Ibarra, F; Téllez-Bañuelos, MC	1

Other Studies

1 other study(ies) available for alliin and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Differential effects of alliin and allicin on apoptosis and senescence in luminal A and triple-negative breast cancer: Caspase, ΔΨm, and pro-apoptotic gene involvement. Fundamental & clinical pharmacology, 2020, Volume: 34, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cysteine; Disulfides; Female; Flow Cytometry; Garlic; Humans; Phytotherapy; Sulfinic Acids; Triple Negative Breast Neoplasms	2020

Article

Year

Differential effects of alliin and allicin on apoptosis and senescence in luminal A and triple-negative breast cancer: Caspase, ΔΨm, and pro-apoptotic gene involvement.

Fundamental & clinical pharmacology, 2020, Volume: 34, Issue:6

Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cysteine; Disulfides; Female; Flow Cytometry; Garlic; Humans; Phytotherapy; Sulfinic Acids; Triple Negative Breast Neoplasms

2020